DexCom Inc. (DXCM)
Health Care5 articles
Price chart
Why is DXCM moving today?
-1.9%DXCM is -1.9% today, inside the ordinary range for a session (under 3%). No stories about it reached the feed in the last 24 hours.
What this does not prove. A story on the same day is evidence of timing, not of cause: it explains a move only if it accounts for the size and the direction, and most single-stock moves carry a sector or index component too. Nothing here is a forecast.
Source: Yahoo Finance - quote as of 2 days ago
DexCom Inc. (DXCM) overview
DexCom makes continuous glucose-monitoring systems for diabetes.
DXCM is a member of the S&P 500. It sits in the Health Care sector. That sector covers pharmaceutical, biotech, device and managed-care companies.
DexCom Inc. trades on the NasdaqGS under the ticker symbol DXCM. The most recent market data puts the share price at about $86.04. That is down 1.90% on the session. At that price the company is worth roughly $32.47B.
Over the past 52 weeks, DXCM has traded between $54.11 and $92.59. Shares change hands at a trailing price-to-earnings (P/E) ratio of about 34.1. The P/E ratio sets the share price against a year of earnings. A higher number means the market is paying more for each dollar the company earns.
Key statistics
Source: Yahoo Finance - quote as of 2 days ago
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch DXCM
DXCM is one of the larger names in the Health Care sector, so investors follow it closely. It tends to move with the rest of the sector. This page sums up each DXCM story as it breaks, and tags it bullish, bearish or neutral.
What moves DXCM
- Earnings. DXCM reports results four times a year. A surprise against the estimate tends to move the stock that day.
- Analyst calls. Upgrades, downgrades and new price targets change what the market expects from DXCM.
- Sector news. Health Care stocks often move together, so a rival's news can move DXCM too.
Market Mood
Latest DXCM news
DexCom (DXCM) Stock Reaches 52-Week High of 91.99 USD
DexCom (DXCM) stock has reached a 52-week high of 91.99 USD. This significant point could indicate strong investor confidence and market interest in the company's performance and future prospects. A rise to this level suggests positive momentum in DexCom's market presence. For investors, this level may serve as a critical point to assess potential entry or exit strategies in relation to DexCom's stock trajectory.
Read More: DexCom (DXCM) Stock Reaches 52-Week High of 91.99 USD
Deutsche Bank Lists Healthcare Stocks DexCom (DXCM), Insulet (PODD)
Deutsche Bank has identified DexCom (DXCM) and Insulet (PODD) as top healthcare stocks for investors. The bank noted various factors, including growth potential and market trends, that could influence these companies' performances. Specific target prices and earnings projections were not disclosed in the article. This report may affect investor sentiment towards the healthcare sector, particularly for stocks within this category.
Read More: Deutsche Bank Lists Healthcare Stocks DexCom (DXCM), Insulet (PODD)
DEXCOM (DXCM) Files Form 144 on May 15, 2023
On May 15, 2023, Dexcom (DXCM) filed a Form 144 with the SEC. This form is typically used to notify the SEC of a proposed sale of stock by an affiliate. The specific details regarding the number of shares to be sold or the price were not disclosed. Such filings can indicate potential changes in stock ownership that may impact market perceptions and trading activity.
Read More: DEXCOM (DXCM) Files Form 144 on May 15, 2023
DexCom (DXCM) Trading at $64.62 with P/E Ratios 30.92 and 25.91
DexCom, Inc. (DXCM) shares traded at $64.62 as of April 20th. The company reported trailing and forward P/E ratios of 30.92 and 25.91, respectively. DexCom has achieved an average revenue growth of 17.4% annually over the past three years, with projections suggesting 15.2% growth ahead. The launch of the Stelo over-the-counter CGM and the G7 15-day sensor is expected to expand the market and improve gross margins to 63-64%, potentially increasing user retention and capturing millions of new insured lives. DexCom is targeting aggressive growth in international markets, particularly in Western Europe, Japan, and Australia.
Read More: DexCom (DXCM) Trading at $64.62 with P/E Ratios 30.92 and 25.91
Dexcom (DXCM) EVP Brown Sells $107K in Shares
Dexcom's (DXCM) Executive Vice President, Brown, sold shares worth $107,000. This transaction may raise questions among investors about future company performance and insider sentiment. Typically, large insider sales can influence market perception regarding the stock, particularly if there are no accompanying positive developments. The timing and context of such sales can also impact trading volumes and market reactions.
Read More: Dexcom (DXCM) EVP Brown Sells $107K in SharesMore Health Care stocks
Frequently asked questions
Is DexCom Inc. in the S&P 500?
Yes. DexCom Inc. trades as DXCM and is a member of the S&P 500. The index lists it in the Health Care sector.
What sector is DXCM in?
DXCM sits in the Health Care sector of the S&P 500.
Where can I find the latest DXCM news?
Right here. This page collects recent DXCM news and market analysis. Every story gets an AI summary and a bullish, bearish or neutral tag.
What is DexCom Inc.'s stock price?
DXCM last traded at about $86.04. Prices move all through the session, so this is the latest quote rather than a live one.
What is DexCom Inc.'s market cap?
DXCM is worth roughly $32.47B. Market cap is the share price times the number of shares outstanding.
What is DXCM's P/E ratio?
DXCM trades at a trailing P/E ratio of about 34.1. The ratio compares the share price with earnings per share over the past year.